Antares Pharma to Present at the Cowen and Company 36th Annual Healthcare Conference
Mar 02, 2016 12:00 pm UTC| Business
EWING, N.J., March 02, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 36th Annual Healthcare Conference on...
Spark Therapeutics, Inc. to Host Conference Call on March 9th at 8:30 a.m. to Discuss 2015 Results
Mar 02, 2016 12:00 pm UTC| Business
PHILADELPHIA, March 02, 2016 -- Spark Therapeutics (NASDAQ:ONCE) today announced that it will host a conference call on Wednesday, March 9, 2016 at 8:30 a.m. Eastern to report corporate and financial results for the...
SKY Perfect JSAT Awards Kratos Contract to Provide TT&C Antenna and RF System for JCSAT-16 Satellite
Mar 02, 2016 12:00 pm UTC| Business
SAN DIEGO, March 02, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Kratos ISI business unit was awarded a contract by SKY...
Amedisys Closes Associated Home Care Acquisition
Mar 02, 2016 12:00 pm UTC| Business
BATON ROUGE, La., March 02, 2016 -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, as of March 1, 2016, has closed on the previously announced acquisition of Associated Home...
NeuroDerm to Present at Upcoming Investor Conferences
Mar 02, 2016 12:00 pm UTC| Business
REHOVOT, Israel, March 02, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will...
Immunomedics to Present at Cowen and Company 36th Annual Health Care Conference
Mar 02, 2016 12:00 pm UTC| Business
MORRIS PLAINS, N.J., March 02, 2016 -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that the Company will present at the Cowen and Company36th AnnualHealth Care Conference on Wednesday, March 9, 2016 at 10:00 a.m....
Mar 02, 2016 12:00 pm UTC| Business
SAN DIEGO, March 02, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company's fourth quarter and full...